Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Macklin

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Muscle & Nerve|June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform TrialEric A Macklin, James D Berry, Brittney A Harkey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2015
Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhageSergi Martinez-Ramirez, Jose-Rafael Romero, Ashkan Shoamanesh, et al.
JMIR Research Protocols|August 27, 2025
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational StudyAudrey Hoyt, Casey Dorney, Peggy Auinger, et al.
Parkinsonism & Related Disorders|September 25, 2021
Seeking progress in disease modification in Parkinson diseaseCodrin Lungu, Jesse M Cedarbaum, Ted M Dawson, et al.
Brain : a Journal of Neurology|August 12, 2025
Design considerations for C9orf72 disease prevention trialsMichael Benatar, Adam M Staffaroni, Joanne Wuu, et al.
Neurology|March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trialsLeonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Plos One|February 22, 2017
Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel DiseaseBraden Kuo, Manoj Bhasin, Jolene Jacquart, et al.
Plos One|May 1, 2015
Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel diseaseBraden Kuo, Manoj Bhasin, Jolene Jacquart, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 6, 2017
Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposiumGary L Pattee, Emily K Plowman, Benjamin R Brooks, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 18, 2023
The natural history of ALS: Baseline characteristics from a multicenter clinical cohortAlex Berger, Matteo Locatelli, Ximena Arcila-Londono, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Muscle & Nerve|June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform TrialEric A Macklin, James D Berry, Brittney A Harkey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2015
Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhageSergi Martinez-Ramirez, Jose-Rafael Romero, Ashkan Shoamanesh, et al.
JMIR Research Protocols|August 27, 2025
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational StudyAudrey Hoyt, Casey Dorney, Peggy Auinger, et al.
Parkinsonism & Related Disorders|September 25, 2021
Seeking progress in disease modification in Parkinson diseaseCodrin Lungu, Jesse M Cedarbaum, Ted M Dawson, et al.
Brain : a Journal of Neurology|August 12, 2025
Design considerations for C9orf72 disease prevention trialsMichael Benatar, Adam M Staffaroni, Joanne Wuu, et al.
Neurology|March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trialsLeonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Plos One|February 22, 2017
Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel DiseaseBraden Kuo, Manoj Bhasin, Jolene Jacquart, et al.
Plos One|May 1, 2015
Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel diseaseBraden Kuo, Manoj Bhasin, Jolene Jacquart, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 6, 2017
Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposiumGary L Pattee, Emily K Plowman, Benjamin R Brooks, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 18, 2023
The natural history of ALS: Baseline characteristics from a multicenter clinical cohortAlex Berger, Matteo Locatelli, Ximena Arcila-Londono, et al.
Pageof 20